In case you missed it, this commercial for Cue COVID tests made its debut during the Super Bowl. Cue lab-quality COVID-19 tests are at-home, molecular tests that need no prescription or special ...

The quantified self and quantified health trends frequently overlap — but few startups are quite as tightly screwed into that sticking place as Cue. Not yet anyway. This San Diego-based startup, which ...

SAN DIEGO, March 16, 2022 /PRNewswire/ -- Cue Health ("Cue") (Nasdaq: HLTH), the healthcare technology company behind the most accurate at-home COVID-19 test* in the U.S., today announced that its ...

Cue Health, best known for its at-home COVID-19 molecular test, will launch its own virtual health platform, pushing the company outside of the diagnostics space. The direct-to-consumer platform, ...

The global diagnostics market was valued at approximately $180 billion in 2022 and is projected to grow to over $348 billion by 2030. Some of the key drivers of that growth are molecular diagnostics ...

A contributed photo from Cue Health shows how the test can be administered and read via a cartridge reader connected to a mobile device. Public school districts across the country are on the lookout ...

San Diego, California-based Cue, not to be confused with fertility tracker company Clue, raised $7.5 million in a round led by SherpaVentures with participation from existing investor Immortalana.

San Diego-based startup Cue believes the future of personal health fits in a small plastic box that — linked up to a smartphone or tablet — will let people monitor and quantify their personal health ...

The quantified self movement has been mostly focused on athletes and people trying to be active and measure their progress, but in the last year or so it has branched into the medical realm. Cue is ...